UniProt ID | PIWL1_HUMAN | |
---|---|---|
UniProt AC | Q96J94 | |
Protein Name | Piwi-like protein 1 | |
Gene Name | PIWIL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 861 | |
Subcellular Localization | Cytoplasm . Component of the meiotic nuage, also named P granule, a germ-cell-specific organelle required to repress transposon activity during meiosis. Also present in chromatoid body. | |
Protein Description | Endoribonuclease that plays a central role in postnatal germ cells by repressing transposable elements and preventing their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons. Directly binds methylated piRNAs, a class of 24 to 30 nucleotide RNAs that are generated by a Dicer-independent mechanism and are primarily derived from transposons and other repeated sequence elements. Strongly prefers a uridine in the first position of their guide (g1U preference, also named 1U-bias). Not involved in the piRNA amplification loop, also named ping-pong amplification cycle. Acts as an endoribonuclease that cleaves transposon messenger RNAs. Besides their function in transposable elements repression, piRNAs are probably involved in other processes during meiosis such as translation regulation. Probable component of some RISC complex, which mediates RNA cleavage and translational silencing. Also plays a role in the formation of chromatoid bodies and is required for some miRNAs stability. Required to sequester RNF8 in the cytoplasm until late spermatogenesis; RNF8 being released upon ubiquitination and degradation of PIWIL1.; Isoform 3: May be a negative developmental regulator. [PubMed: 12037681] | |
Protein Sequence | MTGRARARARGRARGQETAQLVGSTASQQPGYIQPRPQPPPAEGELFGRGRQRGTAGGTAKSQGLQISAGFQELSLAERGGRRRDFHDLGVNTRQNLDHVKESKTGSSGIIVRLSTNHFRLTSRPQWALYQYHIDYNPLMEARRLRSALLFQHEDLIGKCHAFDGTILFLPKRLQQKVTEVFSKTRNGEDVRITITLTNELPPTSPTCLQFYNIIFRRLLKIMNLQQIGRNYYNPNDPIDIPSHRLVIWPGFTTSILQYENSIMLCTDVSHKVLRSETVLDFMFNFYHQTEEHKFQEQVSKELIGLVVLTKYNNKTYRVDDIDWDQNPKSTFKKADGSEVSFLEYYRKQYNQEITDLKQPVLVSQPKRRRGPGGTLPGPAMLIPELCYLTGLTDKMRNDFNVMKDLAVHTRLTPEQRQREVGRLIDYIHKNDNVQRELRDWGLSFDSNLLSFSGRILQTEKIHQGGKTFDYNPQFADWSKETRGAPLISVKPLDNWLLIYTRRNYEAANSLIQNLFKVTPAMGMQMRKAIMIEVDDRTEAYLRVLQQKVTADTQIVVCLLSSNRKDKYDAIKKYLCTDCPTPSQCVVARTLGKQQTVMAIATKIALQMNCKMGGELWRVDIPLKLVMIVGIDCYHDMTAGRRSIAGFVASINEGMTRWFSRCIFQDRGQELVDGLKVCLQAALRAWNSCNEYMPSRIIVYRDGVGDGQLKTLVNYEVPQFLDCLKSIGRGYNPRLTVIVVKKRVNTRFFAQSGGRLQNPLPGTVIDVEVTRPEWYDFFIVSQAVRSGSVSPTHYNVIYDNSGLKPDHIQRLTYKLCHIYYNWPGVIRVPAPCQYAHKLAFLVGQSIHREPNLSLSNRLYYL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
14 | Symmetric dimethylarginine | ARARGRARGQETAQL HHHHHHHCCHHHHHH | 46.06 | - | |
14 | Methylation | ARARGRARGQETAQL HHHHHHHCCHHHHHH | 46.06 | - | |
18 | Phosphorylation | GRARGQETAQLVGST HHHCCHHHHHHHCCC | 16.30 | 29978859 | |
24 | Phosphorylation | ETAQLVGSTASQQPG HHHHHHCCCCCCCCC | 17.20 | 29978859 | |
25 | Phosphorylation | TAQLVGSTASQQPGY HHHHHCCCCCCCCCC | 25.13 | 29978859 | |
27 | Phosphorylation | QLVGSTASQQPGYIQ HHHCCCCCCCCCCCC | 29.45 | 29978859 | |
32 | Phosphorylation | TASQQPGYIQPRPQP CCCCCCCCCCCCCCC | 11.76 | 29978859 | |
49 | Methylation | AEGELFGRGRQRGTA CCCCCCCCCCCCCCC | 29.77 | - | |
53 | Methylation | LFGRGRQRGTAGGTA CCCCCCCCCCCCCCC | 42.97 | - | |
55 | Phosphorylation | GRGRQRGTAGGTAKS CCCCCCCCCCCCCHH | 25.07 | 22210691 | |
107 | Phosphorylation | VKESKTGSSGIIVRL CHHCCCCCCCEEEEE | 30.53 | - | |
122 | Phosphorylation | STNHFRLTSRPQWAL ECCCEEECCCCCEEE | 20.59 | - | |
123 | Phosphorylation | TNHFRLTSRPQWALY CCCEEECCCCCEEEE | 46.70 | - | |
183 | Phosphorylation | QKVTEVFSKTRNGED HHHHHHHHHCCCCCE | 37.99 | 24505115 | |
185 | Phosphorylation | VTEVFSKTRNGEDVR HHHHHHHCCCCCEEE | 28.33 | 24505115 | |
338 | Phosphorylation | TFKKADGSEVSFLEY CCCCCCCCCCHHHHH | 35.06 | 24719451 | |
370 | Methylation | VSQPKRRRGPGGTLP ECCCCCCCCCCCCCC | 60.74 | - | |
388 | Phosphorylation | MLIPELCYLTGLTDK HHHHHHHHHHCCHHH | 21.66 | 28634298 | |
390 | Phosphorylation | IPELCYLTGLTDKMR HHHHHHHHCCHHHHH | 12.04 | 28634298 | |
393 | Phosphorylation | LCYLTGLTDKMRNDF HHHHHCCHHHHHCCC | 34.61 | 28634298 | |
410 | Phosphorylation | MKDLAVHTRLTPEQR HHHHHHHHCCCHHHH | 22.30 | 30576142 | |
413 | Phosphorylation | LAVHTRLTPEQRQRE HHHHHCCCHHHHHHH | 22.84 | 30576142 | |
489 | Phosphorylation | TRGAPLISVKPLDNW CCCCCEEEEEECCCE | 31.60 | 24719451 | |
517 (in isoform 3) | Ubiquitination | - | 48.65 | 21906983 | |
519 | Phosphorylation | IQNLFKVTPAMGMQM HHHHHHCCHHCCCCC | 13.11 | 24114839 | |
550 | Phosphorylation | RVLQQKVTADTQIVV HHHHHHCCCCCEEEE | 26.33 | 29507054 | |
561 | Phosphorylation | QIVVCLLSSNRKDKY EEEEEEECCCCCCHH | 16.78 | 29507054 | |
562 | Phosphorylation | IVVCLLSSNRKDKYD EEEEEECCCCCCHHH | 40.39 | 29507054 | |
564 | Methylation | VCLLSSNRKDKYDAI EEEECCCCCCHHHHH | 50.96 | 115388099 | |
603 | Ubiquitination | TVMAIATKIALQMNC HHHHHHHHHHHHHCC | 19.57 | 2190698 | |
603 (in isoform 2) | Ubiquitination | - | 19.57 | 21906983 | |
603 (in isoform 1) | Ubiquitination | - | 19.57 | 21906983 | |
643 | Phosphorylation | DMTAGRRSIAGFVAS CCCCCCCCHHHHHHH | 18.54 | - | |
650 | Phosphorylation | SIAGFVASINEGMTR CHHHHHHHHCHHHHH | 22.20 | - | |
736 | Phosphorylation | RGYNPRLTVIVVKKR CCCCCCEEEEEEECC | 14.96 | - | |
781 | Phosphorylation | WYDFFIVSQAVRSGS HEEEEEEEHHHHCCC | 13.96 | 26074081 | |
786 | Phosphorylation | IVSQAVRSGSVSPTH EEEHHHHCCCCCCCE | 28.90 | 26074081 | |
788 | Phosphorylation | SQAVRSGSVSPTHYN EHHHHCCCCCCCEEE | 22.22 | 26074081 | |
790 | Phosphorylation | AVRSGSVSPTHYNVI HHHCCCCCCCEEEEE | 26.27 | 26074081 | |
792 | Phosphorylation | RSGSVSPTHYNVIYD HCCCCCCCEEEEEEC | 29.50 | 26074081 | |
794 | Phosphorylation | GSVSPTHYNVIYDNS CCCCCCEEEEEECCC | 17.38 | 26074081 | |
798 | Phosphorylation | PTHYNVIYDNSGLKP CCEEEEEECCCCCCH | 12.56 | 26074081 | |
801 | Phosphorylation | YNVIYDNSGLKPDHI EEEEECCCCCCHHHH | 42.47 | 26074081 | |
860 | Phosphorylation | SLSNRLYYL------ CCCCCEECC------ | 15.55 | 18083107 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PIWL1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PIWL1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PIWL1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DICER_HUMAN | DICER1 | physical | 14749716 | |
STMN1_HUMAN | STMN1 | physical | 26317901 | |
TBA1B_HUMAN | TUBA1B | physical | 26317901 | |
TBB3_HUMAN | TUBB3 | physical | 26317901 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...